Recombinant Anti-TIGIT Antibody (V3S-0723-FY241) (CAT#: V3S-0723-FY241)

Send Inquiry
  • fig1

Datasheet

MSDS

COA

Sub Cat Application  
V3S-1124-YC1968 WB; FC; ELISA; Block Inquiry
V3S-0522-YC397 ELISA; FC; Block Inquiry
V3S-0522-YC396 ELISA; FC Inquiry
Summary
Property
Applications
Protocols
Target

Summary

Description This is a recombinant human antibody that specifically targets human TIGIT. The antibody effectively binds to wild type human TIGIT with an EC₅₀ of 1.28 nM. The monoclonal antibody possesses the ability to activate T cells and natural killer cells significantly by preventing the interaction between TIGIT and CD 155. They have potential applications in cancer treatment, infectious disease treatment, and other areas.
Clonality Monoclonal
Host Species Human
Target Species Human
Isotype IgG1, kappa

Property

Expression Species HEK293F or CHO cell line
Conjugation Unconjugated
Purity >95%
Endotoxin <1 EU/mg
Form Liquid
Purification Protein A purified
Sterility 0.2 μM filtered
Formulation PBS, pH 7.4
Preservation No preservatives
Stabilizer No stabilizers
Storage Store at 4°C within one or two weeks. Store at -20°C for long term. Avoid repeated freeze/thaw cycles. Refer to the COA file for specifics.

Applications

Application WB; FC; ELISA; Block

Protocols

ELISA Enzyme-Linked Immunosorbent Assay Protocol
WB Western Blot Protocol
FC Flow Cytometry Protocol

Target

Target TIGIT
Alternative Name T Cell Immunoreceptor With Ig And ITIM Domains; V-Set And Immunoglobulin Domain-Containing Protein 9; V-Set And Transmembrane Domain-Containing Protein 3; T-Cell Immunoreceptor With Ig And ITIM Domains; VSIG9, VSTM3; VSIG9
Gene ID 201633
UniProt Q495A1
Research Area Immunology
For research use only, not directly for clinical use.
banner banner
© 2024 Creative Biolabs. All Rights Reserved.
antibody
ISO 9001 Certified - Creative Biolabs Quality Management System.
Online Inquiry